| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 32753598
|
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
|
Nature Communications
|
10.1038/s41467-020-17717-0
|
2020
|
| 33662628
|
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
|
Genomics, Proteomics & Bioinformatics
|
10.1016/j.gpb.2020.10.005
|
2021
|
| 40479056
|
Enhancer RNA–mediated transcriptional regulatory programs reveal the malignant progression of glioma
|
Science Advances
|
10.1126/sciadv.adu9487
|
2025
|
| 38205245
|
Comprehensive characterization and database construction of immune repertoire in the largest Chinese glioma cohort
|
iScience
|
10.1016/j.isci.2023.108661
|
2023
|
| 39363097
|
Molecular mechanisms and diagnostic model of glioma-related epilepsy
|
NPJ Precision Oncology
|
10.1038/s41698-024-00721-8
|
2024
|
| 40247989
|
DEP domain‑containing 1 is a prognostic biomarker associated with the cell cycle in gliomas
|
Oncology Letters
|
10.3892/ol.2025.15022
|
2025
|
| 40226936
|
Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF ‐Risk Signature
|
Cancer Reports
|
10.1002/cnr2.70158
|
2025
|
| 36295489
|
Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction
|
Medicina
|
10.3390/medicina58101327
|
2022
|
|
